Overview

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

Status:
NOT_YET_RECRUITING
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label extension (OLE) study of MHB018A in subjects with moderate-to-severe TED.
Phase:
PHASE3
Details
Lead Sponsor:
Minghui Pharmaceutical (Hangzhou) Ltd